SLTM Share Price

Open 2.92 Change Price %
High 2.93 1 Day 0.00 0.00
Low 2.92 1 Week 0.00 0.00
Close 2.92 1 Month 0.00 0.00
Volume 1008658 1 Year 0.00 0.00
52 Week High 21.48
52 Week Low 0.00
SLTM Important Levels
Resistance 2 2.93
Resistance 1 2.93
Pivot 2.92
Support 1 2.91
Support 2 2.91
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ETRM 0.07 0.00%
AAPL 113.86 1.55%
AAPL 113.86 1.55%
More..
NASDAQ USA Top Gainers Stocks
HTCO 11.00 62.96%
LOCM 0.09 50.00%
OPXA 1.21 40.70%
QKLS 0.18 38.46%
ZAZA 0.08 33.33%
MOSY 0.46 31.43%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PPHM 0.40 25.00%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
BGMD 0.05 -37.50%
More..

Solta Medical, Inc (NASDAQ: SLTM)

SLTM Technical Analysis 5
As on 23rd Jan 2014 SLTM Share Price closed @ 2.92 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.24 & Strong Buy for SHORT-TERM with Stoploss of 2.44 we also expect STOCK to react on Following IMPORTANT LEVELS.
SLTM Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
Solta Medical, Inc ( NASDAQ USA Symbol : SLTM )
Sector : Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus And Other Stocks in Same Sector
ARTC
48.54 0.03 (0.06 %)
LT : Strong Buy
ST : Strong Buy
PMTI
13.41 -0.05 (-0.37 %)
LT : Strong Buy
ST : Sell
SLTM
2.92 0.00 (0.00 %)
LT : Strong Buy
ST : Strong Buy
SPNC
23.90 0.35 (1.49 %)
LT : Strong Buy
ST : Buy
SLTM Other Details
Segment EQ
Market Capital 193320512.00
Sector Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus
Industry
Offical website
SLTM Address
SLTM
N/A
SLTM Latest News
Solta Medical Agrees To Be Acquired By Valeant, But Another Bid Might Emerge   Seeking Alpha   - 23rd Dec 13
Valeant to acquire Solta Medical for $236 million   Reuters   - 16th Dec 13
Solta Medical explores sale after loss exceeds estimate   Reuters   - 12th Nov 13
Voce Capital Pushes For Acquisition Of Solta Medical, Activist Investor David ...   Seeking Alpha   - 09th Aug 13
Solta Medical CEO steps down as company revamps sales strategy   San Francisco Business Times (blog)   - 07th Aug 13
Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc.   PR Newswire (press release)   - 24th May 13
Solta Medical to Acquire Sound Surgical Technologies   PR Newswire (press release)   - 30th Jan 13
Solta Medical And BTL Industries Resolve Patent Dispute   PR Newswire (press release)   - 13th Sep 12
Solta Medical Reports FDA Clearance Received for Second Generation LipoSonix ...   PR Newswire (press release)   - 25th Oct 11
Solta Medical Announces Thermage CPT™ and Fraxel re:store® Dual Systems ...   PR Newswire (press release)   - 28th Jun 10
Interactive Technical Analysis Chart Solta Medical, Inc ( SLTM NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Solta Medical, Inc
SLTM Business Profile
Solta Medical, Inc. designs, develops, manufactures and markets professional and consumer energy-based medical device systems for aesthetic applications. The Company's systems are cleared by the United States Food and Drug Administration (FDA) for dermatological procedures performed in the physician led, professional assist, and personal care markets. The Company�s portfolio of products includes six brands that are primarily designed for aesthetic applications: The Fraxel re:pair system provides ablative laser skin resurfacing while the non-ablative Fraxel platform and Clear + Brilliant systems provide treatment for skin rejuvenation. The Thermage system provides non-invasive skin tightening and the Liposonix system provides non-invasive body contouring. Isolaz and CLARO provide options to resolve acne. In January 2014, Valeant Pharmaceuticals International Inc 's wholly-owned subsidiary Valeant Pharmaceuticals International acquired Solta Medical Inc.